Literature DB >> 22082370

Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8.

Lionel B Ivashkiv1, Baohong Zhao, Kyung-Hyun Park-Min, Masamichi Takami.   

Abstract

Inflammation plays a key role in excessive bone loss in conditions such as rheumatoid arthritis and periodontitis. An important paradigm in immunology is that inflammatory factors activate feedback inhibition mechanisms to restrain inflammation and limit associated tissue damage. We hypothesized that inflammatory factors would activate similar feedback mechanisms to restrain bone loss in inflammatory settings. We have identified three mechanisms that inhibit osteoclastogenesis and are induced by inflammatory factors such as toll-like receptor ligands and cytokines; downregulation of expression of costimulatory molecules such as TREM-2; induction of shedding, and thereby inactivation of the M-CSF receptor c-Fms, leading to decreased RANK transcription; and induction of transcriptional repressors such as interferon regulatory factor 8. It is likely that these mechanisms work in a complementary and cooperative manner to fine tune the extent of osteoclastogenesis in inflammatory settings, and their augmentation may represent an alternative therapeutic approach to suppress bone resorption.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082370      PMCID: PMC3263822          DOI: 10.1111/j.1749-6632.2011.06217.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  45 in total

Review 1.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.

Authors:  Tomohiko Tamura; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

3.  CpG oligonucleotides: novel regulators of osteoclast differentiation.

Authors:  Wei Zou; Harry Schwartz; Stefan Endres; Gunther Hartmann; Zvi Bar-Shavit
Journal:  FASEB J       Date:  2002-03       Impact factor: 5.191

4.  Stimulation by toll-like receptors inhibits osteoclast differentiation.

Authors:  Masamichi Takami; Nacksung Kim; Jaerang Rho; Yongwon Choi
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

5.  Dual modulation of osteoclast differentiation by lipopolysaccharide.

Authors:  Wei Zou; Zvi Bar-Shavit
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

6.  RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.

Authors:  Ping Li; Edward M Schwarz; Regis J O'Keefe; Lin Ma; Brendan F Boyce; Lianping Xing
Journal:  J Bone Miner Res       Date:  2004-02       Impact factor: 6.741

Review 7.  Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors.

Authors:  Baohong Zhao; Lionel B Ivashkiv
Journal:  Arthritis Res Ther       Date:  2011-07-28       Impact factor: 5.156

8.  Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Authors:  K Kobayashi; N Takahashi; E Jimi; N Udagawa; M Takami; S Kotake; N Nakagawa; M Kinosaki; K Yamaguchi; N Shima; H Yasuda; T Morinaga; K Higashio; T J Martin; T Suda
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

9.  DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.

Authors:  Juha Paloneva; Jami Mandelin; Anna Kiialainen; Tom Bohling; Johannes Prudlo; Panu Hakola; Matti Haltia; Yrjo T Konttinen; Leena Peltonen
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

10.  Impaired differentiation of osteoclasts in TREM-2-deficient individuals.

Authors:  Marina Cella; Cecilia Buonsanti; Carey Strader; Takayuki Kondo; Andrea Salmaggi; Marco Colonna
Journal:  J Exp Med       Date:  2003-08-11       Impact factor: 14.307

View more
  11 in total

1.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

Review 2.  Mechanisms involved in normal and pathological osteoclastogenesis.

Authors:  Kyung-Hyun Park-Min
Journal:  Cell Mol Life Sci       Date:  2018-04-18       Impact factor: 9.261

3.  Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling.

Authors:  Kyung-Hyun Park-Min; Eun Young Lee; Neal K Moskowitz; Elisha Lim; Sun-Kyeong Lee; Joseph A Lorenzo; Chuanxin Huang; Ari M Melnick; P Edward Purdue; Steven R Goldring; Lionel B Ivashkiv
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

4.  Sex-based differential regulation of bacterial-induced bone resorption.

Authors:  M S Valerio; D S Basilakos; J E Kirkpatrick; M Chavez; J Hathaway-Schrader; B A Herbert; K L Kirkwood
Journal:  J Periodontal Res       Date:  2016-08-11       Impact factor: 4.419

5.  Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation.

Authors:  Kyung-Hyun Park-Min; Elisha Lim; Min Joon Lee; Sung Ho Park; Eugenia Giannopoulou; Anna Yarilina; Marjolein van der Meulen; Baohong Zhao; Nicholas Smithers; Jason Witherington; Kevin Lee; Paul P Tak; Rab K Prinjha; Lionel B Ivashkiv
Journal:  Nat Commun       Date:  2014-11-13       Impact factor: 14.919

6.  The Cell Surface Markers Expression in Postmenopausal Women and Relation to Obesity and Bone Status.

Authors:  Mira Horváthová; Silvia Ilavská; Kornélia Štefíková; Michaela Szabová; Zora Krivošíková; Eva Jahnová; Jana Tulinská; Viera Spustová; Martin Gajdoš
Journal:  Int J Environ Res Public Health       Date:  2017-07-11       Impact factor: 3.390

7.  Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.

Authors:  Alan Sucur; Zrinka Jajic; Marinko Artukovic; Marina Ikic Matijasevic; Branimir Anic; Darja Flegar; Antonio Markotic; Tomislav Kelava; Sanja Ivcevic; Natasa Kovacic; Vedran Katavic; Danka Grcevic
Journal:  Arthritis Res Ther       Date:  2017-06-15       Impact factor: 5.156

8.  OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis.

Authors:  Emily Gwyer Findlay; Lynett Danks; Jodie Madden; Mary M Cavanagh; Kay McNamee; Fiona McCann; Robert J Snelgrove; Stevan Shaw; Marc Feldmann; Peter Charles Taylor; Nicole J Horwood; Tracy Hussell
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

9.  Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.

Authors:  Zhiqiang Liu; Jingda Xu; Haiyan Li; Yuhuan Zheng; Jin He; Huan Liu; Yuping Zhong; Yong Lu; Bangxing Hong; Mingjun Zhang; Pei Lin; Juan Du; Jian Hou; Jianfei Qian; Larry W Kwak; Qing Yi; Jing Yang
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  Alteration of Homeostasis in Pre-osteoclasts Induced by Aggregatibacter actinomycetemcomitans CDT.

Authors:  Dione Kawamoto; Ellen S Ando-Suguimoto; Bruno Bueno-Silva; Joseph M DiRienzo; Marcia P A Mayer
Journal:  Front Cell Infect Microbiol       Date:  2016-03-31       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.